XML 66 R41.htm IDEA: XBRL DOCUMENT v3.25.0.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Benefit
Income tax expense (benefit) consists of the following:
Years Ended December 31,
(in millions)202420232022
Current:
Federal$3.4 $3.4 $(0.5)
State1.5 1.8 1.9 
Foreign1.2 0.2 0.5 
Total current6.1 5.4 1.9 
Deferred:
Federal(15.5)(51.8)(25.8)
State(5.5)(5.2)(4.8)
Foreign3.1 0.1 (2.9)
Change in valuation allowance15.6 52.6 3.0 
Total deferred(2.3)(4.3)(30.5)
Total income tax expense (benefit)
$3.8 $1.1 $(28.6)
Schedule of Loss Before Income Taxes
Loss before income taxes consists of the following:
Years Ended December 31,
(in millions)202420232022
United States$(125.4)$(263.2)$(141.3)
Foreign1.9 1.0 0.7 
Total$(123.5)$(262.2)$(140.6)
Schedule of Differences Between Statutory Federal Income Tax Rate and Income Taxes Reported
The differences between income taxes at the statutory federal income tax rate and income taxes reported in the Consolidated Statements of Operations were as follows:
Years Ended December 31,
(in millions)202420232022
Federal income tax benefit at the statutory rate
$(25.9)21.0 %$(54.9)21.0 %$(29.5)21.0 %
State income taxes, net of federal benefit(2.4)1.9 %(4.1)1.6 %(3.3)2.3 %
Research and development credits(0.4)0.3 %(1.6)0.6 %(3.5)2.5 %
Uncertain tax positions2.8 (2.3)%3.7 (1.4)%0.6 (0.4)%
Stock-based incentive awards
0.8 (0.6)%1.2 (0.5)%2.5 (1.8)%
Foreign rate differential3.3 (2.7)%(0.4)0.2 %— — %
Change in valuation allowance15.7 (12.7)%52.6 (20.1)%2.6 (1.8)%
Non-deductible officer compensation3.9 (3.2)%3.0 (1.1)%3.5 (2.5)%
Acquisitions and dispositions
5.1 (4.1)%0.1 — %(0.1)0.1 %
Other, net0.9 (0.7)%1.5 (0.7)%(1.4)0.9 %
Total income tax expense (benefit)
$3.8 (3.1)%$1.1 (0.4)%$(28.6)20.3 %
Schedule of Components of Deferred Tax Assets and Liabilities
The significant components of the Company’s deferred tax assets and liabilities were comprised of the following:
December 31,
(in millions)20242023
Deferred tax assets:
Net operating loss carryforwards$62.7 $77.1 
Stock compensation expense6.6 5.0 
Research and development credits20.6 20.8 
Lease liability24.4 28.0 
Capitalized research and development costs
54.3 38.4 
Accrued expenses and liabilities16.5 22.5 
Other, net— 3.2 
Total gross deferred tax assets185.1 195.0 
Less valuation allowance(111.9)(95.0)
Total deferred tax assets73.2 100.0 
Deferred tax liabilities:
Intangible assets55.5 84.2 
Lease right-of-use assets13.3 15.5 
Property, plant and equipment3.2 1.9 
Other, net0.8 — 
Total deferred tax liabilities72.8 101.6 
Net deferred tax asset (liability)
$0.4 $(1.6)
Schedule of Net Operating Loss and Research Credit Carryforwards (Tax Effected)
At December 31, 2024, the Company had the following net operating loss and research credit carryforwards (tax effected), with their respective expiration periods. Certain carryforwards are subject to the limitations of Section 382 and 383 of the Internal Revenue Code as indicated:
Carryforwards (in millions)
Amount
Subject to
Sections 382, 383
Expires
beginning in year
Through
Federal net operating loss$32.2 Yes2033Indefinite
Federal capital loss13.8 No 20262029
Utah net operating loss0.9 NoIndefiniteIndefinite
California net operating loss5.0 Yes20292044
Other state net operating loss6.3 YesVariousVarious
Foreign net operating losses (various jurisdictions)4.3 NoVariousVarious
Federal research credit10.5 Yes20272044
Utah research credit4.9 No20242038
California research credit5.2 NoIndefiniteIndefinite
Schedule of Unrecognized Tax Benefits The Company’s gross unrecognized tax benefits as of the years ended December 31, 2024, 2023, and 2022, and the changes in those balances are as follows: 
Years Ended December 31,
(in millions)202420232022
Unrecognized tax benefits at the beginning of period$48.1 $43.9 $32.1 
Gross increases - current year tax positions1.0 0.8 12.9 
Gross increases - prior year tax positions2.6 3.6 1.6 
Gross decreases - prior year tax positions— (0.2)(2.0)
Gross decreases - settlements— — (0.7)
Unrecognized tax benefits at end of year$51.7 $48.1 $43.9 
Interest and penalties in year-end balance$8.8 $6.4 $4.1